How one St. Louis company is using sequencing to identify microbes that naturally control pests and boost agricultural yields
Public/private partnership expands access to comprehensive genomic profiling to improve patient care and advance drug discovery
At ESHG in Vienna, Illumina representatives engaged with an impressive group of geneticists and entrepreneurs
How artificial intelligence and automation are enabling precision medicine to become the standard of care
At ASCO 2022, an oncology panel discusses the benefits and practices of comprehensive genomic profiling
| 日期 | 发表 | 标题 |
|---|---|---|
| 2022年3月17日 | Genome Web | UK Researchers Aim to Discern New Polygenic Risk Scores from 5 Million Genotypes |
| 2022年3月17日 | San Diego Metro Magazine | Illumina Accelerator invests in seven additional genomics startups |
| 2022年3月16日 | Genome Web | Illumina Accelerator Invests in Seven Additional Genomics Startups |
| 2022年2月10日 | San Diego Union Tribune | Illumina rings up strong financial results, updates antitrust probe of Grail acquisition |
| 2022年2月10日 | Barron's | Illumina’s Sales Grew, But Biotech Investors Are Hard to Impress |
